Maggie Fick

2 weeks ago | reuters.com | Jacob Gronholt-Pedersen |Maggie Fick

Danish businessman Lars Rebien Sorensen, former CEO of Novo Nordisk for 16 years and current chair of the Novo Nordisk Foundation, who joins the board of Novo Nordisk A/S as an observer, poses in this handout image released on January 31, 2023.

2 weeks ago | jp.reuters.com | Maggie Fick

デンマークの製薬大手ノボノルディスクは１６日、ラース・ヨルゲンセン最高経営責任者（ＣＥＯ）が退任すると発表した。写真は２０２４年５月、ペンハーゲンで撮影（２０２５年 ロイター/Tom Little） ［コペンハーゲン １６日 ロイター］ - デンマークの製薬大手ノボノルディスク(NOVOb.CO), opens new tabは１６日、ラース・ヨルゲンセン最高経営責任者（ＣＥＯ）が退任すると発表した。後任が決まるまではＣＥＯ職にとどまる。 広報担当者によると、投資部門を通じて同社の経営権を握るノボノルディスク財団が今年４月の会合でヨルゲンセン氏の早期退任を要求した。 ヨルゲンセン氏の指揮下で肥満症治療薬の「ウゴービ」と「ゼップバウンド」の販売が大きく伸び、収益性の高い肥満症治療薬市場で快走したものの、今後は優位性が失われることが懸念されている。 同社の株価は昨年６月に過去最高値を付けた後、大きく下落している。特に米同業イーライリリー(LLY.N), opens new...

3 weeks ago | wdez.com | Patrick Wingrove |Maggie Fick

By Patrick Wingrove and Maggie Fick(Reuters) -As Denmark’s Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its largest market, analysts told Reuters. Novo, which manufactures the popular weight-loss drug Wegovy, said on Friday its current CEO will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

3 weeks ago | wmbdradio.com | Patrick Wingrove |Maggie Fick

By Patrick Wingrove and Maggie Fick(Reuters) -As Denmark’s Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its largest market, analysts told Reuters. Novo, which manufactures the popular weight-loss drug Wegovy, said on Friday its current CEO will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

3 weeks ago | whbl.com | Patrick Wingrove |Maggie Fick

By Patrick Wingrove and Maggie Fick(Reuters) -As Denmark’s Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its largest market, analysts told Reuters. Novo, which manufactures the popular weight-loss drug Wegovy, said on Friday its current CEO will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.